SecSonar.com

Gain Therapeutics, Inc. (GANX)

Gain Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Gain Therapeutics, Inc. (GANX) is a Biotechnology company based in US with a market capitalization of $82.5M. Free cash flow was negative at -$18.5M. This page tracks GANX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 23 employees · IPO Mar 19, 2021

Valuation

Valuation & price

$1.75 · as of May 17, 2026 · -58.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.45

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$4.18$2.82$1.46Jul 25Dec 25Jul 26Jul 7, 25$1.60Jul 9, 25$1.77Jul 11, 25$1.73Jul 15, 25$1.70Jul 17, 25$1.61Jul 21, 25$1.58Jul 23, 25$1.68Jul 25, 25$1.69Jul 29, 25$1.57Jul 31, 25$1.46Aug 4, 25$1.47Aug 6, 25$1.55Aug 11, 25$1.46Aug 13, 25$1.55Aug 15, 25$1.73Aug 19, 25$1.69Aug 21, 25$1.81Aug 25, 25$1.84Aug 27, 25$1.86Aug 29, 25$1.99Sep 3, 25$1.92Sep 5, 25$1.76Sep 9, 25$1.71Sep 11, 25$1.72Sep 16, 25$1.63Sep 18, 25$1.70Sep 22, 25$1.74Sep 24, 25$1.74Sep 26, 25$1.79Sep 30, 25$1.77Oct 2, 25$1.86Oct 6, 25$2.22Oct 8, 25$2.07Oct 10, 25$1.97Oct 14, 25$2.04Oct 16, 25$1.81Oct 21, 25$2.10Oct 23, 25$1.97Oct 27, 25$1.95Oct 29, 25$1.82Oct 31, 25$1.96Nov 4, 25$1.66Nov 6, 25$1.90Nov 10, 25$2.49Nov 12, 25$2.95Nov 14, 25$2.83Nov 18, 25$2.85Nov 20, 25$2.85Nov 25, 25$2.92Nov 28, 25$3.50Dec 2, 25$3.06Dec 4, 25$3.50Dec 8, 25$3.99Dec 10, 25$4.18Dec 12, 25$4.14Dec 16, 25$3.86Dec 18, 25$2.25Dec 22, 25$3.19Dec 24, 25$3.22Dec 29, 25$3.16Jan 2, 26$3.18Jan 6, 26$2.55Jan 8, 26$2.44Jan 12, 26$2.14Jan 14, 26$2.20Jan 16, 26$1.81Jan 21, 26$1.97Jan 23, 26$2.05Jan 27, 26$2.06Jan 29, 26$1.92Feb 2, 26$1.78Feb 4, 26$1.76Feb 9, 26$1.79Feb 11, 26$1.74Feb 13, 26$1.81Feb 18, 26$1.83Feb 20, 26$1.94Feb 24, 26$2.74Feb 26, 26$2.48Mar 2, 26$2.71Mar 4, 26$2.57Mar 6, 26$3.05Mar 10, 26$2.83Mar 12, 26$2.75Mar 17, 26$2.62Mar 19, 26$1.90Mar 23, 26$1.89Mar 25, 26$1.96Mar 27, 26$1.83Mar 31, 26$1.94Apr 2, 26$1.85Apr 7, 26$1.85Apr 9, 26$1.84Apr 13, 26$1.87Apr 15, 26$2.14Apr 17, 26$2.13Apr 22, 26$2.04Apr 24, 26$1.97Apr 28, 26$1.85Apr 30, 26$1.89May 4, 26$1.90May 6, 26$1.91May 8, 26$1.82May 12, 26$1.80May 14, 26$1.82May 18, 26$1.62May 20, 26$1.65May 22, 26$1.78May 28, 26$2.02Jun 1, 26$1.96Jun 3, 26$1.79Jun 5, 26$1.70Jun 9, 26$1.65Jun 11, 26$1.69Jun 15, 26$1.75Jun 17, 26$1.78Jun 22, 26$1.85Jun 24, 26$1.74Jun 26, 26$1.75Jul 2, 26$1.93
$1.4452-week range$4.18
Loading valuation history…

Fundamentals

Key fundamentals

$82.5M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$18.5M

Free cash flow (USD)

-$20.1M

Net debt

Net cash position

44.1%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$20.6KFY 2019$41.3KFY 2020$28.9KFY 2021$165.0KFY 2022$140.1KFY 2023$55.2KFY 2024$0.00FY 2025$0.00
$20.6K$0

Free cash flow by year

2018 → 2025

FY 2018$-752.5KFY 2019$-1.9MFY 2020$-3.3MFY 2021$-12.5MFY 2022$-14.8MFY 2023$-18.9MFY 2024$-18.9MFY 2025$-18.5M
-$752.5K-$18.5M

Gross margin by year

2021 → 2023

FY 2021100.0%FY 2022100.0%FY 2023100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventFDA AuthorizationJun 29, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 25, 2026Filing
  • 8-K eventClinical Data ReleaseMay 26, 2026Filing
  • 8-K eventEarnings ReleaseMay 11, 2026Filing
  • Quarterly report10-Q FiledMay 11, 2026Filing

Questions

Frequently asked questions

What is Gain Therapeutics, Inc.'s market cap?

Gain Therapeutics, Inc. (GANX) has a market capitalization of $82.5M.

What is GANX's P/E ratio?

A meaningful P/E ratio is not available for GANX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is GANX's price-to-book (P/B) ratio?

GANX trades at 4.45 times book value per share.

Are insiders buying GANX stock?

SEC Form 4 filings show no open-market insider buys at Gain Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

HYFT

MindWalk Holdings Corp.

$82M

CSBR

Champions Oncology, Inc.

$81M

COYA

Coya Therapeutics, Inc.

$86.3M

VTVT

vTv Therapeutics Inc.

$86.7M

NRXP

NRx Pharmaceuticals, Inc.

$78.1M

PLRX

Pliant Therapeutics, Inc.

$78M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.